TITLE:
A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

CONDITION:
Depressive Disorder, Major

INTERVENTION:
GW597599B

SUMMARY:

      A Placebo Controlled Study Evaluating Efficacy And Safety of Medication In Patients With
      Major Depressive Disorder (MDD)
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Patients meet the diagnosis of Major Depressive Disorder (MDD).

        Exclusion Criteria:

          -  Patients with a primary diagnosis other than MDD.

          -  Patients with a history of schizophrenia, schizoaffective disorders, seizure
             disorders or bipolar affective disorder.

          -  Patients receiving formal psychotherapy or cognitive/behavioral therapy concurrently
             or in the 12 weeks prior to screening visit.

          -  Patient is actively suicidal.

          -  Patients who have a history of migraine headaches.
      
